Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.
about
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Oral tetrahydrouridine and dec ...... e: A randomized phase 1 study.
@en
type
label
Oral tetrahydrouridine and dec ...... e: A randomized phase 1 study.
@en
prefLabel
Oral tetrahydrouridine and dec ...... e: A randomized phase 1 study.
@en
P2093
P2860
P50
P1433
P1476
Oral tetrahydrouridine and dec ...... se: A randomized phase 1 study
@en
P2093
Donald Lavelle
Johara Hassan
John F Tisdale
Joseph DeSimone
Lani Krauz
Maria A Ruiz
Michael Pacini
Philip Woost
Robert Molokie
Santhosh Saraf
P2860
P304
P356
10.1371/JOURNAL.PMED.1002382
P407
P50
P577
2017-09-07T00:00:00Z